Equillium Inc
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
OTHER INFORMATION
Item 5. Other Information
Trading Arrangements
During the three-months ended September 30, 2024, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities set forth in the table below:
| Type of Trading Arrangement · Total Sharesof Common | |||||
|---|---|---|---|---|---|
| Name and Position · Action · Adoption/TerminationDate · Rule10b5-1(1) · Non-Rule10b5-1(2) · Stock to beSold · Expiration Date | |||||
| Christine Zedelmayer, Chief Operating Officer | Termination(3) | July 19, 2024 | X | 322,823 | December 12, 2024 |
| Christine Zedelmayer, Chief Operating Officer | Adoption | July 19, 2024 | X | 596,877 | July 19, 2025 |
(1) Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
(2) “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
(3)Represents the termination of a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) adopted on
December 12, 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.